+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Spinal Cord Stimulation Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805753
The global spinal cord stimulation market value was USD 2.7 billion in 2022, driven by the increasing prevalence of chronic pain conditions. The market size is anticipated to grow at a CAGR of 8.1% during the forecast period of 2023-2031 to achieve a value of USD 5.4 billion by 2031.

Spinal Cord Stimulation: Introduction

Spinal cord stimulators (SCS) are implantable devices used to treat chronic pain conditions, particularly those associated with the spine. These devices deliver electrical impulses to the spinal cord, blocking pain signals and providing relief to patients. SCS systems consist of a pulse generator implanted in the body and leads with electrodes placed near the spinal cord.

The market for spinal cord stimulators is witnessing significant growth due to the increasing prevalence of chronic pain conditions, such as failed back surgery syndrome and complex regional pain syndrome. Additionally, advancements in technology, such as improved battery life, smaller implantable devices, and advanced programming capabilities, have enhanced the effectiveness and usability of spinal cord stimulators.

Key Trends in the Spinal Cord Stimulation Market

Some key trends involved in the spinal cord stimulation market are as follows:
  • Minimally Invasive Approaches: The development of minimally invasive techniques for implanting spinal cord stimulators has gained traction. These approaches reduce surgical trauma, enhance patient comfort, and lead to quicker recovery times
  • Wireless and Remote Programming: Advancements in wireless technology have allowed for remote programming of spinal cord stimulators. Patients can adjust the settings of their device using external devices or smartphone applications, providing more personalized and convenient pain management
  • Expanded Indications: Spinal cord stimulators are increasingly being explored for the treatment of various conditions beyond traditional chronic pain, such as neuropathic pain, peripheral vascular disease, and even neurological disorders like Parkinson's disease and epilepsy
  • Integration with Wearable Devices: Integration of spinal cord stimulators with wearable devices and mobile health technologies allows for continuous monitoring and real-time adjustments of stimulation parameters. This integration enables personalized therapy and better patient outcomes

Spinal Cord Stimulation Market Segmentations

Market Breakup by Product Type

  • Rechargeable Spinal Cord Stimulator Systems
  • Non-Rechargeable Spinal Cord Stimulator Systems

Market Breakup by Applications

  • Sciatica
  • FBS (Failed Back Syndrome)
  • Arachnoiditis
  • Degenerative Disk Disease
  • Others

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Specialty Centres
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Spinal Cord Stimulation Market Scenario

The market for spinal cord stimulators (SCS) is experiencing significant growth, driven by the increasing prevalence of chronic pain conditions and the demand for non-pharmacological pain management solutions. Spinal cord stimulators are implantable devices that deliver electrical impulses to the spinal cord, providing relief to patients suffering from chronic pain.

Several factors contribute to the growth of the spinal cord stimulators market. Firstly, the rising incidence of chronic pain conditions, such as failed back surgery syndrome and complex regional pain syndrome, is fueling the demand for effective treatment options. Additionally, advancements in technology, such as improved battery life, smaller and more sophisticated devices, and enhanced programming capabilities, are making spinal cord stimulators more accessible and efficient.

The market is witnessing a shift towards minimally invasive techniques for implanting spinal cord stimulators. These techniques reduce surgical trauma, enhance patient comfort, and result in faster recovery times. Moreover, the integration of wireless and remote programming capabilities allows patients to adjust the device settings using external devices or smartphone applications, offering greater convenience and personalization
Expanding the indications for spinal cord stimulators beyond chronic pain is another trend in the market. Researchers are exploring the use of these devices for conditions like neuropathic pain, peripheral vascular disease, and neurological disorders. This broader application potential opens up new avenues for growth and innovation in the market.

Furthermore, the integration of spinal cord stimulators with wearable devices and mobile health technologies is on the rise. This integration enables continuous monitoring and real-time adjustments of stimulation parameters, leading to improved patient outcomes and satisfaction.

Overall, the spinal cord stimulators market is expected to continue its growth trajectory, driven by the increasing prevalence of chronic pain conditions, technological advancements, and the need for personalized and convenient pain management solutions. Manufacturers are investing in research and development to further enhance device performance, patient comfort, and long-term outcomes, ensuring a promising future for the market.

Spinal Cord Stimulation Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Nevro Corp
  • St. Jude Children's Research Hospital
  • Synapse Biomedical Inc
  • NeuroSigma Inc
  • Medtronic
  • Greatbatch
  • NDI Medical LLC
  • NeuroPace Inc
  • Abbott
  • Autonomic Technologies Inc
  • Beijing PINS Medical Co., Ltd
  • Cirtec Medical Corporation
  • Boston Scientific Corporation
  • Stimwave LLC
  • Saluda Medical Pty Ltd

Table of Contents

1 Preface2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Spinal Cord Stimulation Market Analysis
8.1 Key Industry Highlights
8.2 Global Spinal Cord Stimulation Historical Market (2018-2022)
8.3 Global Spinal Cord Stimulation Market Forecast (2023-2028)
8.4 Global Spinal Cord Stimulation Market by Type
8.4.1 Rechargeable
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Non- Rechargeable
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Spinal Cord Stimulation Market by Disease
8.5.1 Failed Back Surgery Syndrome (FBSS)
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Degenerative Disc Disease (DDD)
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Complex Regional Pain Syndrome (CRPS)
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Arachnoiditis
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Ischemic Limb Pain
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2022)
8.5.5.3 Forecast Trend (2023-2028)
8.5.6 Others
8.6 Global Spinal Cord Stimulation Market by End User
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Ambulatory Surgical Units
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Specialty Clinics
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.7 Global Spinal Cord Stimulation Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Spinal Cord Stimulation Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Spinal Cord Stimulation Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Spinal Cord Stimulation Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Bangladesh
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Spinal Cord Stimulation Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Mexico
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Argentina
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Spinal Cord Stimulation Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 South Africa
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 Nigeria
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Abbott Laboratories
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Medtronic Plc
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Boston Scientific Corporation
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Nevro Corp.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Stimwave LLC,
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Others
16 Key Trends and Developments in the Market

Companies Mentioned

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corporation
  • Nevro Corp.
  • Stimwave LLC,

Methodology

Loading
LOADING...

Table Information